Fideuram Asset Management Ireland dac Invests $1.55 Million in HCA Healthcare, Inc. $HCA

Fideuram Asset Management Ireland dac bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 3,323 shares of the company’s stock, valued at approximately $1,551,000.

Other institutional investors have also made changes to their positions in the company. National Pension Service lifted its position in shares of HCA Healthcare by 2.9% during the third quarter. National Pension Service now owns 626,585 shares of the company’s stock worth $267,051,000 after purchasing an additional 17,531 shares in the last quarter. Nordea Investment Management AB raised its holdings in HCA Healthcare by 11.2% in the fourth quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock valued at $507,393,000 after acquiring an additional 108,849 shares in the last quarter. Savant Capital LLC raised its holdings in HCA Healthcare by 37.7% in the third quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock valued at $1,938,000 after acquiring an additional 1,246 shares in the last quarter. AlphaQuest LLC raised its holdings in HCA Healthcare by 2,855.2% in the third quarter. AlphaQuest LLC now owns 5,999 shares of the company’s stock valued at $2,557,000 after acquiring an additional 5,796 shares in the last quarter. Finally, Hudson Bay Capital Management LP raised its holdings in HCA Healthcare by 154.5% in the third quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company’s stock valued at $2,000,000 after acquiring an additional 2,849 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

HCA has been the topic of several recent analyst reports. Royal Bank Of Canada cut their price target on shares of HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Sanford C. Bernstein dropped their target price on shares of HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating on the stock in a report on Tuesday, April 28th. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a report on Wednesday, March 4th. Leerink Partners dropped their target price on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Finally, Barclays dropped their target price on shares of HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Sixteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $515.77.

Check Out Our Latest Stock Report on HCA

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $377.72 on Friday. The company has a 50-day simple moving average of $451.94 and a 200-day simple moving average of $480.74. The firm has a market capitalization of $83.79 billion, a P/E ratio of 12.99, a P/E/G ratio of 1.22 and a beta of 1.18. HCA Healthcare, Inc. has a one year low of $330.00 and a one year high of $556.52.

HCA Healthcare (NYSE:HCAGet Free Report) last released its quarterly earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). The firm had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm’s revenue was up 4.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio is currently 10.73%.

About HCA Healthcare

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Further Reading

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.